Capstone Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: Tempe AZ United States (1987)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2004
NCT00131482
First Marketed Drug
2019
bendamustine (treanda)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Celerity Pharmaceuticals | CELERITY PHARMS | Gage Development Company, LLC